Cargando…
Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study
BACKGROUND: There are inconsistent and limited data regarding the risk of myeloid neoplasms (MN) among breast cancer survivors who received radiotherapy (RT) in the absence of chemotherapy. Concern about subsequent MN might influence the decision to use adjuvant RT for women with localized disease....
Autores principales: | Zeidan, Amer M., Long, Jessica B., Wang, Rong, Hu, Xin, Yu, James B., Huntington, Scott F., Abel, Gregory A., Mougalian, Sarah S., Podoltsev, Nikolai A., Gore, Steven D., Gross, Cary P., Ma, Xiaomei, Davidoff, Amy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597231/ https://www.ncbi.nlm.nih.gov/pubmed/28902882 http://dx.doi.org/10.1371/journal.pone.0184747 |
Ejemplares similares
-
Contemporary practice patterns of tyrosine kinase inhibitor use among
older patients with chronic myeloid leukemia in the United
States
por: Shallis, Rory M., et al.
Publicado: (2021) -
Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea
por: Wang, Rong, et al.
Publicado: (2022) -
Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma
por: Huntington, Scott F, et al.
Publicado: (2019) -
Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?
por: Zeidan, Amer M., et al.
Publicado: (2018) -
Changes in Multiple Myeloma Treatment Patterns during the Early COVID-19 Pandemic Period
por: Neparidze, Natalia, et al.
Publicado: (2021)